HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naima Hammoudi Selected Research

(1,5- dihydroxy- 2- oxopyrrolidin- 3- yl)phosphonic acid

7/2019The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naima Hammoudi Research Topics

Disease

9Neoplasms (Cancer)
02/2023 - 08/2011
4Glioma (Gliomas)
10/2022 - 10/2015
2Glioblastoma (Glioblastoma Multiforme)
02/2023 - 10/2022
1Carcinogenesis
10/2015
1Breast Neoplasms (Breast Cancer)
09/2014
1Leukemia
02/2013

Drug/Important Bio-Agent (IBA)

6Phosphopyruvate Hydratase (Enolase)IBA
02/2023 - 01/2016
3EnzymesIBA
10/2022 - 12/2016
2Organophosphonates (Phosphonates)IBA
02/2023 - 10/2022
2ProdrugsIBA
02/2023 - 10/2022
2EstersIBA
02/2023 - 10/2022
1LipidsIBA
10/2022
1Protein Isoforms (Isoforms)IBA
10/2022
1(1,5- dihydroxy- 2- oxopyrrolidin- 3- yl)phosphonic acidIBA
07/2019
1phosphonoacetohydroxamateIBA
12/2016
1ENOblockIBA
01/2016
1Cysteine (L-Cysteine)FDA Link
10/2015
1NF-kappa B (NF-kB)IBA
10/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2015
1Small Interfering RNA (siRNA)IBA
09/2014
1CalciumIBA
02/2013
1OSW 1IBA
02/2013
1Glutamine (L-Glutamine)FDA Link
08/2011

Therapy/Procedure

1Therapeutics
09/2014